TY - JOUR
T1 - The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies
AU - D'Adamo, Patrizia
AU - Fassone, Lucia
AU - Gedeon, Agi
AU - Janssen, Emiel A.M.
AU - Bione, Silvia
AU - Bolhuis, Pieter A.
AU - Barth, Peter G.
AU - Wilson, Meredith
AU - Haan, Eric
AU - Örstavik, Karen Helen
AU - Patton, Michael A.
AU - Green, Andrew J.
AU - Zammarchi, Enrico
AU - Donati, Maria Alice
AU - Toniolo, Daniela
PY - 1997/1/1
Y1 - 1997/1/1
N2 - Barth syndrome (BTHS) is an X-linked disorder characterized clinically by the associated features of cardiac and skeletal myopathy, short stature, and neutropenia. The clinical manifestations of the disease are, in general, quite variable, but cardiac failure as a consequence of cardiac dilatation and hypertrophy is a constant finding and is the most common cause of death in the first months of life. X-linked cardiomyopathies with clinical manifestations similar to BTHS have been reported, and it has been proposed that they may be allelic. We have recently identified the gene responsible for BTHS, in one of the Xq28 genes, G4.5. In this paper we report the sequence analysis of 11 additional familial cases: 8 were diagnosed as possibly affected with BTHS, and 3 were affected with X-linked dilated cardiomyopathies. Mutations in the G4.5 gene were found in nine of the patients analyzed. The molecular studies have linked together what were formerly considered different conditions and have shown that the G4.5 gene is responsible for BTHS (OMIM 302060), X-linked endocardial fibroelastosis (OMIM 305300), and severe X-linked cardiomyopathy (OMIM 300069). Our results also suggest that very severe phenotypes may be associated with null mutations in the gene, whereas mutations in alternative portions or missense mutations may give a 'less severe' phenotype.
AB - Barth syndrome (BTHS) is an X-linked disorder characterized clinically by the associated features of cardiac and skeletal myopathy, short stature, and neutropenia. The clinical manifestations of the disease are, in general, quite variable, but cardiac failure as a consequence of cardiac dilatation and hypertrophy is a constant finding and is the most common cause of death in the first months of life. X-linked cardiomyopathies with clinical manifestations similar to BTHS have been reported, and it has been proposed that they may be allelic. We have recently identified the gene responsible for BTHS, in one of the Xq28 genes, G4.5. In this paper we report the sequence analysis of 11 additional familial cases: 8 were diagnosed as possibly affected with BTHS, and 3 were affected with X-linked dilated cardiomyopathies. Mutations in the G4.5 gene were found in nine of the patients analyzed. The molecular studies have linked together what were formerly considered different conditions and have shown that the G4.5 gene is responsible for BTHS (OMIM 302060), X-linked endocardial fibroelastosis (OMIM 305300), and severe X-linked cardiomyopathy (OMIM 300069). Our results also suggest that very severe phenotypes may be associated with null mutations in the gene, whereas mutations in alternative portions or missense mutations may give a 'less severe' phenotype.
UR - http://www.scopus.com/inward/record.url?scp=16944366521&partnerID=8YFLogxK
U2 - 10.1086/514886
DO - 10.1086/514886
M3 - Article
C2 - 9382096
AN - SCOPUS:16944366521
SN - 0002-9297
VL - 61
SP - 862
EP - 867
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 4
ER -